End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Jul. 26 | Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources | RE |
Jul. 16 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
- Stock
- Equities
- Stock Human Genome Sciences - Nasdaq
- News Human Genome Sciences